Farmacia
Facultat
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red de Cáncer (18)
2024
-
Correction to: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (Scientific Reports, (2022), 12, 1, (13057), 10.1038/s41598-022-17271-3)
Scientific Reports
-
Digital Microscopy Augmented by Artificial Intelligence to Interpret Bone Marrow Samples for Hematological Diseases
Microscopy and Microanalysis, Vol. 30, Núm. 1, pp. 151-159
-
Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers
Biomedicines, Vol. 12, Núm. 3
2023
-
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 7, pp. 2855-2882
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
-
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 9
-
Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index
PLoS ONE, Vol. 18, Núm. 10 OCTOBER
-
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
Nature Communications, Vol. 14, Núm. 1
-
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
The Journal of clinical investigation, Vol. 133, Núm. 7
-
Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia
Leukemia, Vol. 37, Núm. 8, pp. 1649-1659
-
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity
Cell, Vol. 186, Núm. 12, pp. 2628-2643.e21
2022
-
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
Scientific Reports, Vol. 12, Núm. 1
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Journal of Clinical Investigation, Vol. 132, Núm. 7
-
Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation
Molecular Cell, Vol. 82, Núm. 18, pp. 3438-3452.e8
2021
-
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice
Supportive Care in Cancer, Vol. 29, Núm. 8, pp. 4673-4681
2019
-
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
Haematologica, Vol. 104, Núm. 2, pp. 288-296
2018
-
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Nature Communications, Vol. 9, Núm. 1